Closed
0.66 -1.49
24h
Min
0.65
Max
0.68
Income | -58M -51M |
---|---|
Sales | -19M 10M |
EPS | -0.24 |
Profit margin | -486.444 |
Employees | 61 |
EBITDA | -58M -41M |
Recommendations | Strong Buy |
---|---|
12 Months Forecast | +661.19% upside |
Next Earnings | 7 sie 2025 |
---|
Market Cap | 15M 148M |
---|---|
Previous open | 2.15 |
Previous close | 0.66 |
By Trading Central
Confidence
Strong Bearish Evidence
Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.
Price change
By TipRanks
12 Months Forecast
Average 5.1 USD 661.19%
High 7 USD
Low 2 USD
Based on 6 Wall Street analysts offering 12 month price targets forNektar Therapeutics - Dist in the last 3 months.
Selling and administration expenses
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$